These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study. Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149 [TBL] [Abstract][Full Text] [Related]
6. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose. Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model. Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine. Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603 [TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119 [TBL] [Abstract][Full Text] [Related]
11. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
12. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387 [TBL] [Abstract][Full Text] [Related]
13. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T. Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908 [TBL] [Abstract][Full Text] [Related]
14. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471 [TBL] [Abstract][Full Text] [Related]
15. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
16. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents. Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078 [TBL] [Abstract][Full Text] [Related]
17. [Effects of gadobenate dimeglumine on MRI of mouse liver metastasis model constructed by orthotopic transplantation of highly metastatic murine colon carcinoma (C38-OT7): comparison with gadopentetate dimeglumine]. Yoshikawa K; Takamura T; Funahashi Y; Senba T; Ogawa T; Ono H Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jul; 59(8):380-5. PubMed ID: 10459282 [TBL] [Abstract][Full Text] [Related]
18. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents. Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910 [TBL] [Abstract][Full Text] [Related]
19. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017 [TBL] [Abstract][Full Text] [Related]
20. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations. Johansson L; Kirchin MA; Ahlström H Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]